Dolby CEO Sells $1.85M in Stock After Exercising 25K Options
Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman filed a Form 4 for transactions on 06/24/2025.
Rhea-AI Filing Summary
Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman filed a Form 4 for transactions on 06/24/2025.
- Exercised 25,000 options at $45.50.
- Immediately sold the same 25,000 Class A shares at a weighted-average $74.02, generating ≈$1.85 million in gross proceeds.
- Sale represents about 18 % of the shares held in his family trust.
- Post-trade holdings: 114,725 Class A shares (trust), 127,735 unvested RSUs, and 135,615 unexercised options.
The trades were executed under a Rule 10b5-1 plan; no additional corporate events were disclosed.
Positive
- None.
Negative
- CEO Kevin Yeaman sold 25,000 shares (≈$1.85 M), cutting his trust’s stake by ~18 %, a material insider disposition that may signal reduced near-term confidence.
Insights
CEO’s $1.85 M sale viewed as modestly bearish signal.
The exercise-and-sale combo lowers indirect holdings by ~18 % while monetising in-the-money options. Although governed by a 10b5-1 plan, reducing net exposure of 25 K shares may be interpreted as diminished short-term confidence. Yeaman still retains sizable equity through RSUs and options, tempering governance risk, but the cash-out exceeds the $1 M materiality bar, prompting a negative market read-through.
Planned insider sale limits legal risk; optics still negative.
The Rule 10b5-1 structure mitigates information-timing concerns, and the CEO’s remaining equity maintains incentive alignment. However, an 18 % stake reduction by the top executive can pressure sentiment and raise questions on valuation comfort. Absent concurrent insider buying or strategic disclosures, investors may treat the filing as a mild negative indicator rather than a governance red flag.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 25,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 25,000 | $45.50 | $1.14M |
| Sale | Class A Common Stock | 25,000 | $74.0212 | $1.85M |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (4)
- F1. By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
- F2. The shares were sold in multiple transactions at prices ranging from $73.34 to $74.33, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3. Shares held following the reported transactions include 127,735 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
- F4. This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Did Kevin Yeaman increase or decrease his ownership in Dolby?
Was the CEO's transaction executed under a 10b5-1 trading plan?
How many unexercised options does the CEO hold after this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.